Delivery Order SPE2DB20D2002-SPE2DB25FL69W
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of IPOL Vial 5ML, a polio vaccine product. This competitively awarded, non-set-aside contract carries a ceiling value of $5,437.76 with firm fixed pricing and an ultimate completion date of August 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,307.21 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This firm fixed-price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric immunization pharmaceutical requirement within the federal medical supply chain. This award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,677.88 to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML pharmaceutical products. This firm fixed-price, competitively awarded delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,159.48 to AmerisourceBergen Drug Corp for IPOL Vial 5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. IPOL is an inactivated poliovirus vaccine commonly used in federal immunization programs and military healthcare systems. This...
- This delivery order, valued at $132,136, was awarded on July 21, 2025, to AmerisourceBergen Drug Corp for supply of Ipol vial 5ML pharmaceutical products. The contract, which is not set-aside and was competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The Defense Logistics Agency (DLA), which manages the federal medical supply chain, funded this award under firm fixed-price...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-nine thousand, six hundred fifty-eight dollars and eighty-three cents ($39,658.83) to Amerisourcebergen Drug Corporation for 4561651255 IPOL vials (5ml each). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 31, 2023 through August 1, 2023. No set aside designation or subcontractors were identified. The Defense...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL69WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ipol Vial 5ML, a poliomyelitis vaccine product. This firm fixed price delivery order has a ceiling value of $31,302.96 and an ultimate completion date of August 22, 2025, with no set-aside designation. The contract represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. Performance will be executed from the company's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for the polio vaccine reflects AmerisourceBergen's ongoing role as a prime pharmaceutical vendor fulfilling federal immunization and medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 8/21/25 |